1. Home
  2. RNXT vs CCLD Comparison

RNXT vs CCLD Comparison

Compare RNXT & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • CCLD
  • Stock Information
  • Founded
  • RNXT 2012
  • CCLD 1999
  • Country
  • RNXT United States
  • CCLD United States
  • Employees
  • RNXT N/A
  • CCLD N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • CCLD Computer Software: Prepackaged Software
  • Sector
  • RNXT Health Care
  • CCLD Technology
  • Exchange
  • RNXT Nasdaq
  • CCLD Nasdaq
  • Market Cap
  • RNXT 44.6M
  • CCLD 52.5M
  • IPO Year
  • RNXT 2021
  • CCLD 2014
  • Fundamental
  • Price
  • RNXT $1.40
  • CCLD $2.02
  • Analyst Decision
  • RNXT Strong Buy
  • CCLD Buy
  • Analyst Count
  • RNXT 2
  • CCLD 2
  • Target Price
  • RNXT $7.00
  • CCLD $3.00
  • AVG Volume (30 Days)
  • RNXT 210.6K
  • CCLD 616.6K
  • Earning Date
  • RNXT 05-15-2025
  • CCLD 05-06-2025
  • Dividend Yield
  • RNXT N/A
  • CCLD N/A
  • EPS Growth
  • RNXT N/A
  • CCLD N/A
  • EPS
  • RNXT N/A
  • CCLD N/A
  • Revenue
  • RNXT $240,000.00
  • CCLD $112,507,000.00
  • Revenue This Year
  • RNXT $3,927.91
  • CCLD $2.74
  • Revenue Next Year
  • RNXT $219.75
  • CCLD $7.52
  • P/E Ratio
  • RNXT N/A
  • CCLD N/A
  • Revenue Growth
  • RNXT N/A
  • CCLD N/A
  • 52 Week Low
  • RNXT $0.75
  • CCLD $1.14
  • 52 Week High
  • RNXT $1.69
  • CCLD $4.84
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 78.13
  • CCLD 54.09
  • Support Level
  • RNXT $1.17
  • CCLD $1.96
  • Resistance Level
  • RNXT $1.30
  • CCLD $2.14
  • Average True Range (ATR)
  • RNXT 0.08
  • CCLD 0.11
  • MACD
  • RNXT 0.02
  • CCLD -0.01
  • Stochastic Oscillator
  • RNXT 100.00
  • CCLD 29.18

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About CCLD CareCloud Inc.

CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

Share on Social Networks: